SignatureFD’s Akoya BioSciences AKYA Stock Holding History

SignatureFD’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-141	Closed	-$1.35K	–	3280
2022 Q4	$1.35K	Buy	+141	New	+$1.74K	﹤0.01%	2909

Other funds holding AKYA

Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Altium Capital Management New York $42M AUM

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

SignatureFD's AKYA Position: Q1 2023 in Review

SignatureFD sold out of Akoya BioSciences (AKYA) in Q1 2023, closing a stake of 141 shares — an estimated $1.35K sold.

SignatureFD first reported a position in AKYA in Q4 2022 and held it in 1 quarter. The position peaked at $1.35K in Q4 2022. 63 funds tracked by Wall St. Rank hold AKYA as of Q1 2023.

SignatureFD reported no remaining Akoya BioSciences position as of Q1 2023 after selling out during the quarter.
SignatureFD sold 141 Akoya BioSciences shares in Q1 2023, an estimated $1.35K.
SignatureFD first reported a position in Akoya BioSciences in Q4 2022 and held it in 1 quarter.
SignatureFD's Akoya BioSciences position peaked at $1.35K in Q4 2022.
63 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2023.

Based on SignatureFD's 13F filing for Q1 2023, filed 28 Apr 2023.